Protagenic Therapeutics, Inc.Protagenic Therapeutics, Inc.Protagenic Therapeutics, Inc.

Protagenic Therapeutics, Inc.

No trades
See on Supercharts
Market capitalization
‪6.08 M‬USD
−1.15USD
‪−5.00 M‬USD
‪3.55 M‬
Beta (1Y)
0.80

About Protagenic Therapeutics, Inc.

Headquarters
New York
Employees (FY)
3
Founded
1994
ISIN
US74365N2027
FIGI
BBG000HQJ4R5
Protagenic Therapeutics, Inc. operates as a biotechnology company. It engages in the discovery and development of therapeutics to treat stress-related disorders including post-traumatic stress disorder, depression, anxiety, and drug & alcohol addiction. The firm offers PT00114 peptide-based formulations. The company was founded by Garo H. Armen, David A. Lovejoy, and Hartoun Hartounian on February 3, 1994 and is headquartered in New York, NY.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of PTIX is 1.29 USD — it has decreased by 5.84% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Protagenic Therapeutics, Inc. stocks are traded under the ticker PTIX.
Protagenic Therapeutics, Inc. is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
PTIX stock is 11.13% volatile and has beta coefficient of 0.80. Check out the list of the most volatile stocks — is Protagenic Therapeutics, Inc. there?
Yes, you can track Protagenic Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
PTIX stock has fallen by 23.21% compared to the previous week, the month change is a 1.62% fall, over the last year Protagenic Therapeutics, Inc. has showed a 29.44% decrease.
PTIX net income for the last quarter is ‪−1.68 M‬ USD, while the quarter before that showed ‪−1.40 M‬ USD of net income which accounts for −20.02% change. Track more Protagenic Therapeutics, Inc. financial stats to get the full picture.
Today Protagenic Therapeutics, Inc. has the market capitalization of ‪6.08 M‬, it has decreased by 9.47% over the last week.
No, PTIX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PTIX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Protagenic Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
PTIX reached its all-time high on Dec 28, 1998 with the price of 584539200.00 USD, and its all-time low was 0.64 USD and was reached on Mar 18, 2020.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 3.00 employees. See our rating of the largest employees — is Protagenic Therapeutics, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Protagenic Therapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Protagenic Therapeutics, Inc. stock shows the strong sell signal. See more of Protagenic Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.